ITIH5 and neoplasm: Interestingly, the patient group with high ITIH5 expression still demonstrates a favorable overall survival, like in tumor entities such as breast [16] and bladder cancer [19], where ITIH5 is clearly downregulated in the tumor, compared to their normal tissue counterparts.